Interim report January – March 2020
First quarter in brief Comparative figures in Q1 are the Parent Company’s since the Group was formed 1[st] of July 2019. · Net sales amounted to SEK 12.5 million (10.3), which means a sales growth of 22 percent. · Operating profit amounted to SEK 0.8 million (2.9). · Profit for the period amounted to SEK 0.8 million (2.2). · Earnings per share amounted to SEK 0.21 (0.55). · Sales for rolling 12 months amounted to SEK 48,1 million (47.9). Significant events during the first quarter SyntheticMR has received orders directly from hospitals in all priority